These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6332358)

  • 1. Phenotypic and genotypic differences between high- and low-metastatic related tumor lines and the problem of tumor progression and variant generation.
    Schirrmacher V; Dzarlieva R; Altevogt P; Fogel M; Waller CA; Dennis JW; Springer GF; Vlodavsky I; Kramer M; Cheingsong-Popov R
    Symp Fundam Cancer Res; 1983; 36():81-99. PubMed ID: 6332358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.
    Altevogt P; Kurnick JT; Kimura AK; Bosslet K; Schirrmacher V
    Eur J Immunol; 1982 Apr; 12(4):300-7. PubMed ID: 6124426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of metastatic tumor variants to tumor-specific cytotoxic T-lymphocytes not due to defects in expression of restricting major histocompatibility complex molecules in murine cells.
    Altevogt P; Leidig S; Heckl-Oestreicher B
    Cancer Res; 1984 Nov; 44(11):5305-13. PubMed ID: 6333273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines.
    Altevogt P; Fogel M; Cheingsong-Popov R; Dennis J; Robinson P; Schirrmacher V
    Cancer Res; 1983 Nov; 43(11):5138-44. PubMed ID: 6616451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface glycoprotein differences between a highly malignant murine tumor line and a plastic-adherent, less malignant variant.
    Lang E; Altevogt P; Schirrmacher V
    Cancer Detect Prev Suppl; 1987; 1():73-9. PubMed ID: 3480072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system.
    Dzarlieva R; Schirrmacher V; Fusenig NF
    Int J Cancer; 1982 Nov; 30(5):633-42. PubMed ID: 6961115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance.
    Vlodavsky I; Schirrmacher V; Ariav Y; Fuks Z
    Invasion Metastasis; 1983; 3(2):81-97. PubMed ID: 6677623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
    Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
    Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variation in cancer metastasis: immune escape versus immune control.
    Schirrmacher V; Fogel M; Russmann E; Bosslet K; Altevogt P; Beck L
    Cancer Metastasis Rev; 1982; 1(3):241-74. PubMed ID: 6985248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth.
    Benke R; Lang E; Komitowski D; Muto S; Schirrmacher V
    Invasion Metastasis; 1988; 8(3):159-76. PubMed ID: 3259567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment.
    Honsik CJ; Diamant M; Olsson L
    Cancer Res; 1986 Feb; 46(2):940-9. PubMed ID: 3484432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative differences in position of sialylation and surface expression of glycolipids between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1 alpha) from Eb cells.
    Murayama K; Levery SB; Schirrmacher V; Hakomori S
    Cancer Res; 1986 Mar; 46(3):1395-402. PubMed ID: 3484680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.
    Vlodavsky I; Fuks Z; Bar-Ner M; Ariav Y; Schirrmacher V
    Cancer Res; 1983 Jun; 43(6):2704-11. PubMed ID: 6601984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variation in clonal Abelson virus lymphoma cells.
    Green PL; Lamph WW; Dudley J; Arfsten A; Risser R; Lanier LL; Warner NL; Tung JS; Scheid MP
    J Immunol; 1985 Feb; 134(2):1268-75. PubMed ID: 2856928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
    Koyama S; Koike N; Adachi S
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
    J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic tumor cell variants with increased resistance to infection by Semliki Forest virus.
    Barz D; Bosslet K; Schirrmacher V
    J Immunol; 1981 Sep; 127(3):951-4. PubMed ID: 6267134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.
    Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M
    Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.